CAIAFFA, MARIA FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 3.677
EU - Europa 3.506
AS - Asia 1.521
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 2
OC - Oceania 2
Totale 8.732
Nazione #
US - Stati Uniti d'America 3.662
IE - Irlanda 1.089
CN - Cina 1.056
UA - Ucraina 769
SE - Svezia 557
IT - Italia 467
FR - Francia 186
TR - Turchia 153
SG - Singapore 139
FI - Finlandia 124
IN - India 101
GB - Regno Unito 100
DE - Germania 72
BE - Belgio 48
VN - Vietnam 40
CZ - Repubblica Ceca 28
CA - Canada 14
RU - Federazione Russa 13
IR - Iran 12
RO - Romania 12
EU - Europa 10
BR - Brasile 8
RS - Serbia 8
NL - Olanda 7
GR - Grecia 6
TH - Thailandia 4
AT - Austria 3
CL - Cile 3
ES - Italia 3
JO - Giordania 3
PT - Portogallo 3
AU - Australia 2
CH - Svizzera 2
CO - Colombia 2
HK - Hong Kong 2
IL - Israele 2
JP - Giappone 2
MT - Malta 2
PL - Polonia 2
BD - Bangladesh 1
CI - Costa d'Avorio 1
HR - Croazia 1
ID - Indonesia 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
Totale 8.732
Città #
Dublin 1.089
Chandler 588
Jacksonville 539
Dearborn 455
Nyköping 331
Nanjing 278
Ashburn 206
Wilmington 175
Beijing 142
Princeton 122
Nanchang 102
San Mateo 102
Ann Arbor 99
Singapore 91
Woodbridge 72
Shenyang 70
Boardman 67
Des Moines 64
New York 57
Foggia 54
Brussels 47
Jiaxing 46
Hebei 43
Tianjin 43
Kunming 41
Dong Ket 38
Helsinki 37
Bari 31
Pune 29
Changsha 26
Guangzhou 26
Rome 26
Jinan 25
Seattle 24
Los Angeles 21
Hangzhou 20
Brno 19
Auburn Hills 17
London 16
Ningbo 15
Changchun 14
Shanghai 14
Stevenage 13
Zhengzhou 13
Augusta 12
Munich 12
Washington 12
Hilden 11
Milan 11
Taizhou 11
Bologna 9
Hefei 9
Lanzhou 9
Olomouc 9
Toronto 9
Orange 8
Philadelphia 8
Shenzhen 8
Redwood City 7
Timisoara 7
Leawood 6
Ardabil 5
Chicago 5
Saint Petersburg 5
Yiwu 5
Bangkok 4
Belgrade 4
Capua 4
Catania 4
Cisternino 4
Florence 4
Hanover 4
Houston 4
Manfredonia 4
San Marzano Di San Giuseppe 4
Turin 4
Walnut 4
West Jordan 4
Wuxi 4
Bellante 3
Borås 3
Fuzhou 3
Jesi 3
Kozani 3
Mola Di Bari 3
Naples 3
Napoli 3
Nettuno 3
Norwalk 3
Padova 3
Phoenix 3
Qingdao 3
Racale 3
Reggio Calabria 3
Serramazzoni 3
Zibo 3
Alghero 2
Amsterdam 2
Belford Roxo 2
Bollate 2
Totale 5.640
Nome #
Il fenetil estere dell'acido caffeico è un potente inibitore della via metabolica 5-lipossigenasica/leucotrienica 195
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 195
Sviluppo ed applicazione di un protocollo di desensibilizzazione rapida per Rituximab 164
Caratterizzazione di nuovi allergeni alimentari della dieta mediterranea: allergia crociata a fico e gelsi 131
Terapia con Omalizumab nell'asma severo persistente: presentazione di un caso clinico 117
Multicenter double-blind comparative study of terfenadine and cetirizine in hay fever. 109
Fusaproliferin production by Fusarium subglutinans and toxicity to Artemia salina, SF-9 insect cells and IARC/LCL 171 human B-lymphocytes. 108
"Metodo diagnostico in vitro per allergia respiratoria da polline di Cupressus arizonica". 107
Allergy to artichoke: a case report. 106
5-lipoxygenase upregulation by dexamethasone in human mast cells. 106
Caratterizzazione di nuovi allergeni alimentari della dieta mediterranea: allergia al carciofo 103
Terapia con Omalizumab: valutazione di efficacia e tollerabilità in una casistica di 21 soggetti con asma severo non controllato 102
Novel inhibitory effect on 5-lipoxygenase activity by montelukast. Evedence for a noncopetitive mode of action 99
Allergia alimentare a Leguminose della dieta mediterranea: Phaseoulus vulgaris (fagiolo) e Pisum Sativum (pisello) 99
Apoptosis induced by the Fusarium mycotoxin beauvericin in mammalian cells. 98
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean diet 98
Sviluppo ed applicazione di una procedura di monitoring dell'asma persistente basato su registrazione di sintomi e PEF 97
Allergia alimentare da finocchio (Phoeniculum Vulgare) ed altre Apiaceae 97
Olive pollen allergy in Bari, Italy. 96
Tako-tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration. 95
Flaws and improvement in skin testing in Hymenoptera venom allergy. 94
General adverse reaction to aspirin administered by transdermal iontophoresis. 93
Development and application of an improved sympton score and PEF card-based procedure in the management of persistent asthma 91
Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term 91
EFFETTI DEL MONTELUKAST SULLA BIOSINTESI DEI LEUCOTRIENI E SULL'ATTIVITA' ENZIMATICA DELLA 5-LO 89
Biosensori cellulari nella valutazione di nuovi detergenti ecosostenibili. 88
Grape anaphylaxis 88
Cyclooxygenase-2 expression in oral squamous cell carcinoma 88
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy. 87
Wasp immunotherapy induces a long term and IgG4-independent protection. 85
Omalizumab in severe allergic asthma: efficacy assessment by comparison of pre- and post-therapy symptom score and peak espiratory flow (PEF) values. 84
Changes in skin reactivity, specific IgE and IgG levels after 1 year of immunotherapy in olive pollinosis. 84
Beauvericin cytotoxicity to the invertebrate cell line SF-9. 83
Five-lipoxygenase/leukotreiene pathway inhibition by caffeic acid phenethyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-infiammatory properties. 82
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and cypress pollen 82
Significativo declino dei valori di IgE specifiche legate, evidenziato da skin prick tests quantitativi, in pazienti con asma severo trattati con omalizumab 82
Allergens of Arizona cypress (Cupressus arizonica) pollen: characterization of the pollen extract and identification of the allergenic components. 81
TERAPIA CON OMALIZUMAB NELL'ASMA SEVERO NON CONTROLLATO: PRESENTAZIONE DI UN CASO CLINICO 80
Nuove acquisizioni sul meccanismo di azione dei corticosteroidi. 80
Therapy with omalizumab: evaluation of effectiveness and safety in 27 patients with severe uncontrolled asthma. 79
TERAPIA CON OMALIZUMAB NELL'ASMA SEVERO NON CONTROLLATO: VALUTAZIONE DI EFFICACIA E TOLLERABILITA' IN UNA CASISTICA DI TRENTA PAZIENTI 79
Allergeni alimentari emergenti della dieta mediterranea 79
A new subcutaneous protocol for persistent desensitisation to Rituximab. 79
Allergy to pomegranate and artichoke, novel food allergens of the mediterranean diet. 79
Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast 78
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean diet. 78
Flaws and improvements in skin testing in hymenoptera venom allergy 77
Five-lipoxygenase/leukotriene pathway inhibition by caffeic acid phenethyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-inflammatory properties. 76
Airborne Cupressaceae pollen in Southern Italy 75
Purification and fine characterization of the major allergen from Olea europaea pollen extract. 75
Allergia alimentare da finocchio (Phoeniculum vulgare) ed altre Apiaceae 75
Italian real-life experience of omalizumab. 75
Fennel (Foeniculum vulgare); a major allergen of the Mediterranean diet 75
Novel inibitory effect on 5-lipoxygenase by the anti-asthma drug montelukast 74
Monitoring of atmospheric conditions and forecast of olive pollen season. 74
Cyclooxygenase-2 expression in oral squamous cell carcinoma. 73
Omalizumab e monitoraggio retrospettivo dei sintomi e del PEF nell'asma severo non controllato 73
Skin testing technique and precision in stinging insect allergy 72
Fig and mulberry cross-allergy 72
Management dell'anafilassi da alimenti 70
Punti di debolezza ed ottimizzazione dei tests cutanei nell'allergia a veleno di imenotteri 70
Retrospective monitoring in the management of persistent asthma 70
Systemic adverse reaction to diclofenac administered by transdermal iontophoresis. 69
Tako-Tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration. 69
Dermanyssus gallinae in città: serve un approccio multiattoriale in cui il veterinario è decisivo 69
Skin testing technique and precision in stinging insect allergy 68
Indirect food contact in severe fish allergy. 67
Omalizumab and retrospective syntom score and PEF monitoring in severe asthma 67
Leukotriene biosyntesis inhibition and direct 5-lipoxygenase non competitive inhibition by the Cys-LT1 receptor antagonists montelukast ans zafirlukast. 67
Characteristics and treatment regimens across ERS SHARP severe asthma registries 67
Impact of Omalizumab in 21 patients with severe asthma 67
Novel food allergens of the Mediterranean diet. 67
Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin. 66
Food Allergy in Southern Italy. Allergy to cynara scolymus 65
Tests cutanei nel monitoraggio dell'immunoterapia a veleno di imenotteri 65
Efficacia e tollerabilità di Omalizumab (Xolair) dopo due anni di trattamento: studio in 17 soggetti con asma severo 64
Desensitization in Iron Product Allergy 64
Leukotriene biosynthesis inhibition and direct 5-lipoxygenase (5-LO) noncompetitive inhibition by the cys-LT1 receptor antagonist montelukast. 63
Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak espiratory flow values before and after therapy. J Investig Allergol Clin Immunol; 63
Fennel (Foeniculum vulgare) allergy. Nico A, Vacca M, Bellotti A, Di Giacomo M, Giliberti A, Lotti A, Caiaffa MF, Macchia L. 63
L'orticaria (da un punto di vista allergologico) 62
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 62
Italian real-life experience of omalizumab 61
Terapia dell'asma severo con anticorpo monoclonale anti-IgE. Significativo declino dei valori di IgE specifiche legate, evidenziato da Skin Prick Tests Quantitativi. 61
Studi "in vivo" sulla cross-reattività allergenica tra polline di Compositae anemofile e Compositae edibili 59
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study 59
Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera) 59
Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis. A systematic review and meta-analysis. 58
Cost-effectiveness of grass pollen allergen immunotherapy in adults 57
Purification and fine characterization of the major allergen from Olea Europaea pollen extract. 56
Il ruolo organizzativo e pedagogico del Presidente di Corso di Laurea Magistrale in Medicina. 56
The lymphocyte proliferation test (LTP) in the diagnosis of critical cases of delayed drug allergy. 56
Immunological characterization of onion (Allium cepa) allergy 56
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects 55
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and Cypress pollen 54
Retrospective monitoring in the management of persistent asthma. 54
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study 54
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 52
When there is no communication between urban planners and public health operators: urban Dermanyssus gallinae infestations in humans 51
Inibizione della via metabolica 5-lipossigenasica/leucotrienica da parte di sostanze antiossidanti di origine naturale 51
Totale 8.004
Categoria #
all - tutte 44.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.107 0 0 0 0 216 275 246 24 142 26 143 35
2020/20211.087 141 13 123 6 122 66 149 71 172 162 12 50
2021/2022715 102 1 7 23 62 21 26 53 98 70 33 219
2022/20232.690 242 114 121 161 148 247 47 203 1.249 39 59 60
2023/2024620 78 19 28 17 58 227 16 68 1 15 12 81
2024/2025356 108 15 124 74 35 0 0 0 0 0 0 0
Totale 8.973